BRPI0417264A - processos para a preparação de uma batelada de um ingrediente farmacêutico ativo, um recipiente compreendendo criogránulos de um produto alérgeno, e um criogránulo de um produto alérgeno - Google Patents

processos para a preparação de uma batelada de um ingrediente farmacêutico ativo, um recipiente compreendendo criogránulos de um produto alérgeno, e um criogránulo de um produto alérgeno

Info

Publication number
BRPI0417264A
BRPI0417264A BRPI0417264-7A BRPI0417264A BRPI0417264A BR PI0417264 A BRPI0417264 A BR PI0417264A BR PI0417264 A BRPI0417264 A BR PI0417264A BR PI0417264 A BRPI0417264 A BR PI0417264A
Authority
BR
Brazil
Prior art keywords
allergen product
container
cryogranes
processes
active pharmaceutical
Prior art date
Application number
BRPI0417264-7A
Other languages
English (en)
Inventor
Martin Richter-Friis
Signe Kolmos Andersen
Original Assignee
Alk Abello As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alk Abello As filed Critical Alk Abello As
Publication of BRPI0417264A publication Critical patent/BRPI0417264A/pt

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2/00—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
    • B01J2/02—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic by dividing the liquid material into drops, e.g. by spraying, and solidifying the drops
    • B01J2/06—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic by dividing the liquid material into drops, e.g. by spraying, and solidifying the drops in a liquid medium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F26—DRYING
    • F26B—DRYING SOLID MATERIALS OR OBJECTS BY REMOVING LIQUID THEREFROM
    • F26B5/00—Drying solid materials or objects by processes not involving the application of heat
    • F26B5/04—Drying solid materials or objects by processes not involving the application of heat by evaporation or sublimation of moisture under reduced pressure, e.g. in a vacuum
    • F26B5/06—Drying solid materials or objects by processes not involving the application of heat by evaporation or sublimation of moisture under reduced pressure, e.g. in a vacuum the process involving freezing
    • F26B5/065—Drying solid materials or objects by processes not involving the application of heat by evaporation or sublimation of moisture under reduced pressure, e.g. in a vacuum the process involving freezing the product to be freeze-dried being sprayed, dispersed or pulverised
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Mechanical Engineering (AREA)
  • General Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

"PROCESSOS PARA A PREPARAçãO DE UMA BATELADA DE UM INGREDIENTE FARMACêUTICO ATIVO, UM RECIPIENTE COMPREENDENDO CRIOGRáNULOS DE UM PRODUTO ALéRGENO, E UM CRIOGRáNULO DE UM PRODUTO ALéRGENO". A presente invenção refere-se a um processo para a preparação de uma batelada de um ingrediente farmacêutico ativo, por exemplo, um produto alérgeno. A invenção também diz respeito a um recipiente que compreende criogrânulos de uma composição líquida de um produto alérgeno, e a um criogrânulo de um produto alérgeno. Os processos caracterizam a formação de criogrânulos usando um recipiente tendo um meio criogênico (por exemplo, nitrogênio líquido) e armazenamento dos grânulos no mesmo recipiente. Os criogrânulos obtidos podem ser armazenados e manipulados sem secagem por congelamento anterior.
BRPI0417264-7A 2003-12-19 2004-12-17 processos para a preparação de uma batelada de um ingrediente farmacêutico ativo, um recipiente compreendendo criogránulos de um produto alérgeno, e um criogránulo de um produto alérgeno BRPI0417264A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200301896 2003-12-19
US53167903P 2003-12-23 2003-12-23
PCT/DK2004/000878 WO2005058474A1 (en) 2003-12-19 2004-12-17 Cryogranulation and storage method for active pharmaceutical agents

Publications (1)

Publication Number Publication Date
BRPI0417264A true BRPI0417264A (pt) 2007-03-06

Family

ID=34702154

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0417264-7A BRPI0417264A (pt) 2003-12-19 2004-12-17 processos para a preparação de uma batelada de um ingrediente farmacêutico ativo, um recipiente compreendendo criogránulos de um produto alérgeno, e um criogránulo de um produto alérgeno

Country Status (11)

Country Link
US (3) US20050232930A1 (pt)
EP (2) EP1697033B1 (pt)
JP (1) JP5795852B2 (pt)
AU (1) AU2004298719B8 (pt)
BR (1) BRPI0417264A (pt)
CA (1) CA2548249C (pt)
HK (1) HK1096895A1 (pt)
IL (1) IL176116A0 (pt)
MX (1) MXPA06006896A (pt)
RU (1) RU2006126051A (pt)
WO (1) WO2005058474A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060210590A1 (en) 2005-02-03 2006-09-21 Alk-Abello A/S Minor allergen control to increase safety of immunotherapy
EP1798504A1 (en) * 2005-12-19 2007-06-20 Koninklijke Philips Electronics N.V. Method of making dried particles
EP1870649A1 (en) 2006-06-20 2007-12-26 Octapharma AG Lyophilisation targetting defined residual moisture by limited desorption energy levels
WO2010099966A2 (de) * 2009-03-06 2010-09-10 Linde Aktiengesellschaft Verfahren zur herstellung von kosmetika
CA3107195C (en) 2009-11-02 2023-02-14 Mannkind Corporation Apparatus and method for cryogranulating a pharmaceutical composition
WO2011124667A2 (de) 2010-04-09 2011-10-13 Qiagen Gmbh Verfahren zur herstellung von im wesentlichen kugelförmigen lyophilisaten
RU2593778C3 (ru) 2010-06-03 2020-12-21 Альк-Абелло А/С Фармацевтический продукт, содержащий экстракт(ы) аллергена клещей, и способ его получения
US8549768B2 (en) * 2011-03-11 2013-10-08 Linde Aktiengesellschaft Methods for freeze drying
US20130008191A1 (en) * 2011-07-07 2013-01-10 Suchak Naresh J Methods for freezing and thawing proteins
AU2013296803B2 (en) * 2012-08-01 2018-03-08 Eric Ostertag Free flowing, frozen compositions comprising a therapeutic agent
US11207241B2 (en) 2013-03-15 2021-12-28 Phd Preventative Health Care And Diagnostics, Inc. Prefilled medication device, method of making and using the same
EP3046633A4 (en) 2013-09-19 2017-03-15 Allovate, LLC Toothpaste for delivering allergens to oral mucosa

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5242846B2 (pt) 1974-04-03 1977-10-27
JPS6451032A (en) 1987-08-22 1989-02-27 Minoru Hosoya Method for raising hen
US4848094A (en) 1988-04-29 1989-07-18 Union Carbide Corporation Droplet freezing method and apparatus
JPH02187583A (ja) * 1989-01-13 1990-07-23 Yasuto Ozaki 携帯用冷却装置
US5275016A (en) 1992-04-24 1994-01-04 Abaxis, Inc. Cryogenic apparatus
JPH06323712A (ja) * 1993-04-20 1994-11-25 E I Du Pont De Nemours & Co 霧化した極低温液滴の閉じ込め帯域を用いて凍結粒子を製造する方法および装置
IL120202A (en) * 1996-03-07 2001-03-19 Akzo Nobel Nv Container with freeze-dried vaccine components
ATE408690T1 (de) 1998-03-16 2008-10-15 Alk Abello As Mutiertes rekombinantes allergen
AU5131699A (en) 1998-07-31 2000-02-21 Eli Lilly And Company Cryogranulation of activated protein c
SE9903236D0 (sv) * 1999-09-10 1999-09-10 Astra Ab Method to obtain microparticles
US6284283B1 (en) * 1999-10-21 2001-09-04 Alkermes Controlled Therapeutics, Inc. Method of producing sub-micron particles of biologically active agents and uses thereof
AU773735B2 (en) 2000-01-14 2004-06-03 Brown University Research Foundation Micronized freeze-dried particles
US6565888B1 (en) 2000-08-23 2003-05-20 Alkermes Controlled Therapeutics, Inc. Methods and compositions for the targeted delivery of biologically active agents
JP2004521618A (ja) 2000-11-16 2004-07-22 アルカベロ アクチェセルスカプ 新規変異体アレルゲン
AUPR750501A0 (en) * 2001-09-05 2001-09-27 Gauci, Mark Products comprising quantum of bioparticles and method for production thereof
CN1668737A (zh) 2002-05-16 2005-09-14 阿尔克-阿贝洛有限公司 重组Bet.V.1过敏原突变体及其方法和制备
GB0218821D0 (en) * 2002-08-13 2002-09-18 Glaxosmithkline Biolog Sa Novel compositions
US8012505B2 (en) * 2003-02-28 2011-09-06 Alk-Abello A/S Dosage form having a saccharide matrix

Also Published As

Publication number Publication date
CA2548249A1 (en) 2005-06-30
MXPA06006896A (es) 2006-09-04
WO2005058474A1 (en) 2005-06-30
JP5795852B2 (ja) 2015-10-14
AU2004298719B2 (en) 2011-03-24
US20110104216A1 (en) 2011-05-05
AU2004298719B8 (en) 2011-04-07
RU2006126051A (ru) 2008-01-27
WO2005058474A9 (en) 2006-08-03
US8459046B2 (en) 2013-06-11
JP2011105719A (ja) 2011-06-02
EP2272502A1 (en) 2011-01-12
EP1697033A1 (en) 2006-09-06
IL176116A0 (en) 2006-10-05
HK1096895A1 (en) 2007-06-15
US8551491B2 (en) 2013-10-08
US20050232930A1 (en) 2005-10-20
CA2548249C (en) 2013-02-12
AU2004298719A1 (en) 2005-06-30
US20110100030A1 (en) 2011-05-05
EP1697033B1 (en) 2011-04-13

Similar Documents

Publication Publication Date Title
BRPI0417264A (pt) processos para a preparação de uma batelada de um ingrediente farmacêutico ativo, um recipiente compreendendo criogránulos de um produto alérgeno, e um criogránulo de um produto alérgeno
ATE366568T1 (de) Aerosolformulierungen von salmeterol xinafoate
PT88985A (pt) Processo para a preparacao de composicoes farmaceuticas nasais e ou oftalmicas contendo azelastina
DE69727158D1 (de) Pharmazeutische zusammensetzungen enthaltend eine mischung von selbstvernetzter und nichtselbstvernetzter hyaluronsäure zur behandlung von arthropathien
BRPI0009299B1 (pt) formas de administração farmacêuticas mecanicamente estáveis para administração por via oral, e, processo para produzir formas de administração farmacêuticas mecanicamente estáveis.
DE60124294D1 (de) Proinsulin c-peptid enthaltende arzneizubereitung mit verzögerter wirkstofffreigabe
MXPA02001803A (es) Metodos de coformulacion y sus productos.
CA2534664A1 (en) Modafinil compositions
WO1999043636A3 (en) Disubstituted lavendustin a analogs and pharmaceutical compositions comprising the analogs
IL95391A0 (en) Substituted n-(quinolin-2-yl-methoxy)benzyl-sulphonyl-ureas,their preparation and pharmaceutical compositions containing them
CA2463681A1 (en) Ready-to-use paracetamol injection solutions containing propylene glycol as the only cosolvent
HUT55598A (en) Fungicidal composition comprising new amino acid amide derivatives as active ingredient and process for producing the active ingredients
WO2003011249A3 (en) Ophthalmic composition containing n-acetylcysteine for the treat ment of dry-eye syndrome
UA40636C2 (uk) Фармацевтична композиція для одержання стабільного порошку, яка містить як активний компонент асоціацію ацетилсаліцилової кислоти та метоклопраміду, фармацевтичний препарат у формі порошку та спосіб одержання цього препарату
ATE419012T1 (de) Verwendung von 2,5-dihydroxybenzolsulfonsäure- derivaten bei der herstellung eines medikaments zur verstärkung der wirkung anderer arzneimittel zur behandlung der erektilen dysfunktion
ATE109006T1 (de) Pharmazeutische zusammensetzung bestimmt zur behandlung oder vorbeugung von retroviralen infektionen.
ATE205399T1 (de) Eine lagerstabile wässrige lösung zur infusion die einen thrombininhibitor enthält
EP1875905A3 (de) Pharmazeutische Zusammensetzung in Form eines Hydrogels zur transdermalen Verabreichung von Wirkstoffen
WO2004004705A3 (en) Pharmaceutical formulations for preparing drink products
NZ333656A (en) Liquid formulation comprising less 5% w/w saturated polyglycosylated C8-10 glycerides (capryl caproyl macrogol glycerides) and a non-peptide for oro-mucosal administration
BRPI0407850A (pt) processo para fabricação de uma composição farmacêutica contendo o princìpio ativo fenofibrato ou de um de seus derivados, e, comprimido de fenofibrato ou de um de seus derivados
WO2004093867A3 (en) Phenolic acid salts of gabapentin in liquid and/or semi-solid dosage forms and methods of use
WO2001028578A3 (en) A PHARMACEUTICAL COMPOSITION CONTAINING pGLU-GLU-PRO-NH2 AND METHOD FOR TREATING DISEASES AND INJURIES TO THE BRAIN, SPINAL CORD AND RETINA USING SAME
MXPA05009763A (es) 2-(butil-1-sulfonilamino)-n-[1 (r)-(6-metoxipiridin-3-il) propil] benzamida, su uso en forma de un farmaco y preparaciones farmaceuticas que contienen a dicho compuesto.
CA2418227A1 (en) Process for the preparation of 5-hydroxymethyl 2-oxazolidinone and novel intermediate

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B11T Dismissal of application maintained [chapter 11.20 patent gazette]